INTRODUCTION {#sec1-1}
============

Poly(ADP‐ribosyl)ation is a post‐translational modification of proteins mediated by one of the 17 members of the poly(ADP‐ribose) polymerases (PARP; Amé et al.,[2004](#bib3){ref-type="ref"}; Schreiber et al.,[2006](#bib17){ref-type="ref"}). PARP‐1, the founding member of the PARP family, is a molecular sensor of DNA breaks, playing a key role in the spatial and temporal organization of break repair through the local synthesis of poly(ADP‐ribose) (PAR) at damaged sites. In addition to its critical involvement in cellular response to DNA damage, poly(ADP‐ribosyl)ation has been ascribed to regulate various biological processes such as transcription, mitotic segregation, telomere homeostasis, cell proliferation, transformation, and cell death (Schreiber et al.,[2006](#bib17){ref-type="ref"}). The diversity of PAR functions is a consequence of the variety of the functional domains combined to the PARP domain in each PARP family member.

PARP‐9, PARP‐14, and PARP‐15 belong to the subfamily of macroPARPs, associating one to three macro domains to the PARP domain. A macro domain is present within the histone variant macroH2A that is associated to transcriptional repression and X chromosome inactivation (Angelov et al.,[2003](#bib4){ref-type="ref"}). Interestingly, this domain is able to negatively regulate PARP‐1 activity on particular promoters that must remain inactive in the absence of appropriated stimulation or on the inactive X chromosome (Ouararhni et al.,[2006](#bib15){ref-type="ref"}; Nusinow et al.,[2007](#bib13){ref-type="ref"}). Macro domains were recently shown to bind ADP‐ribose and its derivatives (Karras et al.,[2005](#bib12){ref-type="ref"}). Those of PARP‐9 and of some RNA virus encoding nonstructural proteins (from the Severe Acute Respiratory Syndrome Coronavirus SARS‐CoV, the hepatitis E virus, and the Semliki Forest virus) are indeed able to bind poly(ADP‐ribose) (Karras et al.,[2005](#bib12){ref-type="ref"}; Egloff et al.,[2006](#bib7){ref-type="ref"}).

PARP‐9 (also called BAL1, B‐aggressive lymphoma 1) was identified according to its differential expression in diffuse large B cell lymphomas (DLBCL), higher in some chemoresistant tumors with poor prognosis, particularly those associating a brisk host inflammatory response due to tumour infiltration by T lymphocytes and dendritic cells (Aguiar et al.,[2000](#bib1){ref-type="ref"}; Juszczynski et al.,[2006](#bib11){ref-type="ref"}). PARP‐9/BAL1 overexpression stimulates cell migration in vitro, suggesting a role for PARP‐9/BAL1 in the promotion of malignant B cell migration and dissemination in high risk DLBCL (Aguiar et al.,[2000](#bib1){ref-type="ref"}). Murine Parp‐14, also named Coast6, was described as a cofactor of Stat6 in a pathway activated by interleukin 4 (IL‐4; Goenka and Boothby,[2006](#bib8){ref-type="ref"}). Its coactivating property requires functional PARP activity (Goenka et al.,[2007](#bib9){ref-type="ref"}). PARP‐9/BAL1 is also likely a transcription coactivator, its overexpression in B lymphocytes, stimulated by interferon gamma (IFNγ), inducing the transcription of IFNγ‐controlled genes (Juszczynski et al.,[2006](#bib11){ref-type="ref"}).

PARP‐9/BAL1 was shown to interact with BBAP (B‐lymphoma and BAL‐associated protein), a ring finger E3 ligase of the DELTEX family, capable of heterodimerization with DTX members and self‐ubiquitination (Takeyama et al.,[2003](#bib18){ref-type="ref"}). DELTEX proteins participate in Notch signaling pathway that controls cell fate determination, notably in myogenesis, neurogenesis, lymphogenesis, and intestinal homeostasis (Artavanis‐Tsakonas et al.,[1999](#bib5){ref-type="ref"}). BBAP was proposed to regulate the subcellular localization of PARP‐9/BAL1, sequestering it within the cytoplasm (Juszczynski et al.,[2006](#bib11){ref-type="ref"}).

Of interest, genes encoding PARP‐9/BAL1, PARP‐14/BAL2, and PARP‐15/BAL3 but also BBAP are localized within 200 kbp in the 3q21 human chromosomal region (Aguiar et al.,[2005](#bib2){ref-type="ref"}). This region is syntenically conserved in mouse chromosome region 16B3, with the exception of the *PARP‐15* gene, which is absent in mouse (and species other than primates, Schreiber et al.,[2006](#bib17){ref-type="ref"}). Moreover, PARP‐9/BAL1 and BBAP genes are located head‐to‐head, their mRNAs are antisense through their 5′ extremities, and both genes are controlled by a IFNγ‐responsive bidirectional promoter (Juszczynski et al.,[2006](#bib11){ref-type="ref"}). Both genes were found to be overexpressed in DLBCL, with a prominent inflammatory infiltrate (Juszczynski et al.,[2006](#bib11){ref-type="ref"}).

Here, we present a detailed investigation of macroPARPs expression during mouse embryogenesis and in adult tissues. The expression of *Parp‐9* and *Parp‐14* was compared with the expression of *Parp‐1*, used here as a reference gene. Because *Parp‐9* and *Bbap* share a bidirectional promoter, we also examined whether the two genes may display a similar regulation.

RESULTS AND DISCUSSION {#sec1-2}
======================

Expression of *Parp‐9* and *Parp‐14* During Mouse Development {#sec2-1}
-------------------------------------------------------------

In situ hybridization experiments were performed to analyze the expression patterns of *Parp‐9* and *Parp‐14* in comparison with the previously described *Parp‐1* pattern (Schreiber et al.,[2002](#bib16){ref-type="ref"}) at various stages of mouse development. As expected, control sense probes for each gene only showed background labeling (Fig. [1](#fig1){ref-type="fig"}C and data not shown), whereas antisense probes yielded specific labeling patterns. At the earliest time point examined, embryonic day (E) 10.5, as expected *Parp‐1* was expressed at high levels throughout the embryo (Fig. [1](#fig1){ref-type="fig"}A). *Parp‐9* showed a differential expression pattern, with transcripts detected in the neuroepithelium of the brain, particularly in the telencephalic vesicles (Fig. [1](#fig1){ref-type="fig"}B). *Parp‐9* transcripts were also detected in the embryonic gut, notably at the level of the cloaca (Fig. [1](#fig1){ref-type="fig"}B). No expression of *Parp‐14* was detected at this stage of development (data not shown). At E12.5, *Parp‐9* was regionally expressed in the forebrain, namely in the telencephalic vesicles and hypothalamus, and in the epithelium of the nasal cavity (Fig. [3](#fig3){ref-type="fig"}B). Additionally, transcripts were detected in the developing intestine, notably in the midgut loops, and the urogenital sinus (Fig. [4](#fig4){ref-type="fig"}B).

![Expression of *Parp‐1*, *Parp‐9*, and *Parp‐14* during mouse development. **A--H:** Sagittal sections of mouse embryos at embryonic day (E) 10.5 (A--C), 14.5 (D--F), and 17.5 (G,H) hybridized with antisense probes for *Parp‐1* (A,D,G), *Parp‐9* (B,E,H), *Parp‐14* (F) or a control sense probe for *Parp‐9* (C). bl, bladder; cc, cerebral cortex; cb, cerebellum; cl, cloaca; mc, mouth cavity; nc, nasal cavity; ob, olfactory bulb; pi, pituitary; pv, prevertebrae; re, rectum; te, telencephalic vesicle; th, thymus; to, tongue; us, urogenital sinus. The asterisk indicates a nonspecific signal (similarly observed with the sense probe, not shown).](DVDY-237-209-g005){#fig1}

At later developmental stages, between E14.5 and 18.5, *Parp‐9*, like *Parp‐1*, was expressed at highest levels in the developing thymus (Fig. [1](#fig1){ref-type="fig"}D,E,G,H, and see below). *Parp‐1* was also expressed in specific brain regions (olfactory bulb, cerebellar and cerebral cortex, shown for E14.5 and 17.5 in Fig. [1](#fig1){ref-type="fig"}D,G), as well as in the genital ridge, cranial and spinal ganglia (see Schreiber et al.,[2002](#bib16){ref-type="ref"}). *Parp‐9* was expressed in some craniofacial tissues, namely the telencephalic vesicles, hypothalamus, pituitary, olfactory bulb and nasal cavity, illustrated at E14.5 and E17.5, Fig. [1](#fig1){ref-type="fig"}E,H and data not shown) and in the developing intervertebral disks (Fig. [1](#fig1){ref-type="fig"}E, see the caudal prevertebrae). Additionally, *Parp‐9* expression was also regionalized in the epithelium of the developing palate and mouth cavity (Fig. [1](#fig1){ref-type="fig"}E). In the developing intestine, *Parp‐9* transcripts were detected at E14.5 in the midgut loops and the rectum (Fig. [1](#fig1){ref-type="fig"}E). Specific expression was also detected in both epithelial and mesenchymal regions of the urogenital sinus (Fig. [1](#fig1){ref-type="fig"}E). The restricted expression in the posterior part of the gut (duodenum, jejunum, ileum, colon, rectum) was observed until E18.5 and maintained postnatally (Fig. [4](#fig4){ref-type="fig"}, and see below).

or *Parp‐14*, we only observed a weak but significant expression in the thymus, from E14.5 (Fig. [1](#fig1){ref-type="fig"}F) to E18.5 (see Fig. [2](#fig2){ref-type="fig"}). To exclude a possible inefficiency of the probe used, we used throughout our study two distinct *Parp‐14* antisense probes, one hybridizing to the region encoding residues 1106--1622, and a second one hybridizing to the region encoding residues 1600 to 1817 (data not shown). We found comparable results in term of hybridization pattern and intensity, indicating that *Parp‐14* is very weakly expressed during mouse embryogenesis, but also in adult organs (see below).

![Expression of *Parp‐1*, *Parp‐9*, and *Parp‐14* in lymphoid organs during development and in adult mice. **A--F:** Sagittal sections of mouse embryos at embryonic day 14.5 (A--C), 18.5 (D--F) hybridized with antisense probes for *Parp‐1* (A,D), *Parp‐9* (B,E) and *Parp‐14* (C,F). **G--O:** Sections of 12‐week‐old mouse thymus (G--I), spleen (J--L), and lymphoid follicles of distal colon (M--O) hybridized with antisense probes for *Parp‐1* (G,J,M), *Parp‐9* (H,K,N), *Parp‐14* (I,L,O). cx, cortex; FAE, follicle associated epithelium; gc, germinal center; lf, lymphoid follicle; me, medulla; rp, red pulp; wp, white pulp.](DVDY-237-209-g001){#fig2}

Expression of *Parp‐9* and *Parp‐14* in Lymphoid Organs {#sec2-2}
-------------------------------------------------------

In situ hybridization at developmental stages revealed that expression of the *Parp‐9* and *Parp‐14* genes was highest in the developing thymus, as observed for the *Parp‐1* gene (Fig. [1](#fig1){ref-type="fig"}). Expression of *Parp‐9*, *Parp‐14*, and *Parp‐1* was rather homogenous throughout the thymus from E14.5 to E17.5 (Figs. [1](#fig1){ref-type="fig"}D--H, [2](#fig2){ref-type="fig"}A--C and data not shown). At E18.5 (Fig. [2](#fig2){ref-type="fig"}D--F), whereas *Parp‐1* expression was restricted to the cortex of the thymus, where immature lymphocytes proliferate, *Parp‐9* and *Parp‐14* displayed higher expression in the cortex but also significant expression in the medulla. We then analyzed postnatal expression in thymus from 12‐week‐old mice (Fig. [2](#fig2){ref-type="fig"}G--I). *Parp‐1* gene expression was particularly high in the subcapsular zone and the mature cortex, which contains double‐positive (CD4+/CD8+) cells, whereas *Parp‐9* and *Parp‐14* expression was higher in the medulla. Therefore, whereas *Parp‐1* expression seems to be related to T‐cell proliferation, macroParps expression is more likely related to T‐cell selection or maturation. Differential expression was also seen in the adult spleen (Fig. [2](#fig2){ref-type="fig"}J--L), with a moderate expression of the three genes in the marginal zone and the white pulp. In addition, we found that Peyer\'s patches and lymphoid follicles, which are secondary lymphoid organs located in the intestine and colon wall, respectively, also moderately express the three genes (Fig. [2](#fig2){ref-type="fig"}M--O). Of interest, only *Parp‐1* is highly expressed in the germinal centers of Peyer\'s patches and colon lymphoid follicles (Fig. [2](#fig2){ref-type="fig"}M), which correspond to sites of B‐cell selection and proliferation after antigen stimuli.

Expression of *Parp‐9* and *Parp‐14* in the Brain {#sec2-3}
-------------------------------------------------

During mouse development, *Parp‐9* transcripts were detected in the developing forebrain, in the neuroepithelium of the telencephalic vesicles at E10.5 (Fig. [1](#fig1){ref-type="fig"}B) and the neopallial cortex from E12.5 to E18.5 (Fig. [3](#fig3){ref-type="fig"}B, also 1E,H). Expression of *Parp‐9* was also detected in the olfactory bulb and olfactory epithelium of the nasal cavities throughout development. *Parp‐9* transcripts were observed at lower levels in the ventral hypothalamus from E12.5 to E18.5 and in the anterior pituitary from E14.5 to E18.5 (Fig. [1](#fig1){ref-type="fig"}H and data not shown). *Parp‐1* transcripts were more widely distributed in the central nervous system at all developmental stages (Figs. [1](#fig1){ref-type="fig"}A,D,G, [3](#fig3){ref-type="fig"}A). No expression of *Parp‐14* was observed in the developing nervous system (Fig. [1](#fig1){ref-type="fig"} and data not shown).

![Expression of *Parp‐1*, *Parp‐9*, and *Parp‐14* in developing and adult mouse brain. **A--I:** Sagittal sections of mouse embryos at embryonic day 12.5 (A--C) and coronal sections of 12‐week‐old mouse brain hybridized with antisense probes for *Parp‐1* (A,D,G), *Parp‐9* (B,E,H), and *Parp‐14* (C,F,I). CA1--3, hippocampal subregions; cc, cerebral cortex; dg, dentate gyrus; hb, hindbrain; nc, nasal cavity; te, telencephalic vesicle; pl, Purkinje cell layer.](DVDY-237-209-g002){#fig3}

The distribution of *Parp‐1*, *Parp‐9*, and *Parp‐14* transcripts was further investigated on coronal sections of adult mouse brain. *Parp‐9*, like *Parp‐1*, showed expression in neuronal cells forming the stratum granulosum of the dentate gyrus and the stratum pyramidale of the hippocampus (CA 1‐3, Fig. [3](#fig3){ref-type="fig"}D,E). Only *Parp‐1* showed weak expression in cells of the adult cerebral cortex. Transcripts for *Parp‐1* and *Parp‐9* were also detected in the Purkinje cell layer of the cerebellum (Fig. [3](#fig3){ref-type="fig"}G,H). Again, *Parp‐14* showed no expression in the adult brain (Fig. [3](#fig3){ref-type="fig"}F,I). Altogether, our observations indicate a developmentally regulated and regionalized expression of *Parp‐9* gene in the mouse embryonic brain, and a weaker expression in the adult brain, suggesting a possible role for *Parp‐9* in neurogenesis.

Expression of *Parp‐9* and *Parp‐14* in the Gut {#sec2-4}
-----------------------------------------------

At E10.5, *Parp‐9* was expressed at higher levels in the caudal region of the primitive gut (Fig. [1](#fig1){ref-type="fig"}B), whereas *Parp‐1* did not show higher expression than in other regions of the embryo (Fig. [1](#fig1){ref-type="fig"}A). At E12.5 and E14.5, *Parp‐9* transcripts were observed in the urogenital sinus, both in the epithelium and mesenchyme at the base of the bladder and the genital tubercule (Fig. [1](#fig1){ref-type="fig"}E). This finding suggests a specific function of *Parp‐9* in the early development of urogenital regions. From E14.5 to E18.5, expression of *Parp‐9* was detected in the duodenum, midgut loops, and rectum (Fig. [1](#fig1){ref-type="fig"}E, [4](#fig4){ref-type="fig"}B,E). No expression was detected in more anterior foregut derivatives (esophagus, stomach). Interestingly, at late developmental stages from E16.5 to E18.5, a clear difference between *Parp‐1* and *Parp‐9* transcript distributions was observed. The level of *Parp‐1* transcripts was highest in undifferentiated cells at the bottom of the intestinal crypts, in intestine and colon (Fig. [4](#fig4){ref-type="fig"}D). On the opposite, *Parp‐9* expression was detected throughout the entire villi (Fig. [4](#fig4){ref-type="fig"}E). This differential expression pattern was maintained in adulthood. *Parp‐1* expression was detected in the crypts of the duodenum, jejunum, ileum, and colon (Fig. [4](#fig4){ref-type="fig"}F,H, and data not shown). In the colon, expression was extending to the bottom of the crypts, but progressively decreased toward the lumen (Fig. [4](#fig4){ref-type="fig"}H). *Parp‐9* was expressed in the enterocytes of the entire epithelium of the duodenum, jejunum, ileum, and colon (Fig. [4](#fig4){ref-type="fig"}G,I, and data not shown). In duodenum, jejunum, and ileum, *Parp‐9* expression was slightly higher from the bottom of the crypt to the crypt‐villus junction, and gradually decreased toward more differentiated cells along the axis of the villi (Fig. [4](#fig4){ref-type="fig"}G and data not shown). In the colon, expression was homogenous throughout the epithelia, from the crypts to the lumen. The presence of *Parp‐1* in the proliferating cells of the intestinal crypts could be justified by the necessity for the maintenance of genome integrity in intestinal stem cells and progenitors. The presence of *Parp‐9* in the enterocytes of the entire villi suggests on the other hand that *Parp‐9* could be involved in differentiation or migration of the enterocytes, or in their absorptive function. Its expression at embryonic day 12.5, before villi formation (Crosnier et al.,[2006](#bib6){ref-type="ref"}), strongly suggests that it could be involved in morphogenesis of the intestine.

![Expression of *Parp‐1*, *Parp‐9*, and *Parp‐14* in the developing and adult mouse intestine. **A--I:** Sagittal sections of mouse embryos at embryonic day 12.5 (A--C) or 18.5 (D,E), and sections of 12‐week‐old mouse ileum (F,G) and colon (H,I) hybridized with antisense probes for *Parp‐1* (A,D,F,H), *Parp‐9* (B,E,G,I), and *Parp‐14* (C). co, colon; il, ileum; lu, lumen; ml, midgut loop; us, urogenital sinus.](DVDY-237-209-g004){#fig4}

Expression of *Parp‐9* was particularly high in the intestinal epithelium that covers Peyer\'s patches and colon lymphoid follicles, termed the follicle‐associated epithelium (FAE, Fig. [2](#fig2){ref-type="fig"}N). These specialized epithelial cells possess an immune program, rather than the digestive program typical of the adjacent enterocytes of the villi (Hase et al.,[2005](#bib10){ref-type="ref"}). Of interest, *Parp‐14* transcripts were detected in the FAE (Fig. [2](#fig2){ref-type="fig"}O), while barely detectable in the other parts of the gut (data not shown). *Parp‐1* expression was not differential between FAE and other regions of the intestinal epithelium (Fig. [2](#fig2){ref-type="fig"}M). The FAE might be immunologically activated by the immune cells from the lymphoid follicles (Hase et al.,[2005](#bib10){ref-type="ref"}). This finding could explain why *Parp‐9* and *Parp‐14* expression is increased in this epithelium, assuming that both genes could be up‐regulated by immunological signals, as described at least for the *Parp‐9* gene that responds to IFNγ (Juszczynski et al.,[2006](#bib11){ref-type="ref"}).

Comparative Expression Profile of *Bbap* and *Parp‐9* {#sec2-5}
-----------------------------------------------------

The human DELTEX family member BBAP was identified as a PARP‐9 binding protein, that regulates PARP‐9 subcellular localization by a dynamic shuttling mechanism (Aguiar et al.,[2005](#bib2){ref-type="ref"}; Juszczynski et al.,[2006](#bib11){ref-type="ref"}). The genes encoding BBAP and PARP‐9 are located head‐to‐head and controlled by a bidirectional promoter (Juszczynski et al.,[2006](#bib11){ref-type="ref"}). Both genes respond to IFNγ stimulation and are overexpressed in high risk DLBCL associating a prominent immune/inflammatory response (Juszczynski et al.,[2006](#bib11){ref-type="ref"}). This genomic organization of *PARP‐9* and *BBAP* genes is conserved in mouse, with *Parp‐9* and *Bbap* mRNAs being antisense through their respective first exons. For these reasons, we examined whether the tissue distribution of murine *Bbap* transcripts may share some similarities with that of *Parp‐9*, during mouse embryogenesis and in adulthood.

At E10.5, *Bbap* transcripts were detected throughout the embryo, with higher levels in the neuroepithelium of the telencephalic vesicles and the mid‐ and hindbrain regions (Fig. [5](#fig5){ref-type="fig"}A). This expression pattern slightly differs from that of *Parp‐9*, since *Parp‐9* transcripts distribution appeared more regionalized, with higher expression in the anterior part of the telencephalic vesicles and in the cloaca (Fig. [1](#fig1){ref-type="fig"}B). At E12.5 (data not shown) and E14.5 (Fig. [5](#fig5){ref-type="fig"}B), the distribution of *Bbap* transcripts coincided with that of *Parp‐9* transcripts. *Bbap* transcripts were detected at the highest level in the thymus and expression was also observed in the telencephalic vesicles, hypothalamus, anterior pituitary, olfactory bulb, nasal cavity, mouth cavity, urogenital sinus, midgut loops, and rectum (Fig. [5](#fig5){ref-type="fig"}B and data not shown), as observed for *Parp‐9* expression (Fig. [1](#fig1){ref-type="fig"}E). However, a difference was noticed in the relative level of *Parp‐9* and *Bbap* expression between the developing brain and gut at the stages examined, from E10.5 to E14.5: *Parp‐9* transcripts were more abundant in the gut than in the forebrain, contrasting with the distribution of *Bbap* transcripts, more abundant in the brain than in the gut (compare Fig. [5](#fig5){ref-type="fig"}A and B with Fig. [1](#fig1){ref-type="fig"}B and E, respectively). These slight differences in the expression patterns of *Parp‐9* and *Bbap* suggest that despite the fact that the two genes are coexpressed during mouse development, their expression levels might be differentially regulated.

![Expression of *Bbap* during development and in adult mice. **A--H:** Sagittal sections of mouse embryos at embryonic day 10.5 (A) and 14.5 (B), and sections of 12‐week‐old mouse thymus (C), spleen (D), ileum (E), colon (F), and brain (G,H) hybridized with antisense probes for *Bbap*. CA1--3, hippocampal subregions; cc, cerebral cortex; cl, cloaca; cx, cortex; dg, dentate gyrus; hb, hindbrain; in, intestine; me, medulla; nc, nasal cavity; re, rectum; rp, red pulp; th, thymus te, telencephalic vesicle; pl, Purkinje cell layer; wp, white pulp.](DVDY-237-209-g003){#fig5}

Coexpression of *Parp‐9* and *Bbap* was also revealed in mouse adult organs. Like *Parp‐9*, *Bbap* was expressed at higher levels in the medulla of the thymus (Fig. [5](#fig5){ref-type="fig"}C) and the white pulp of the spleen (Fig. [5](#fig5){ref-type="fig"}D), in the epithelium of the duodenum, jejunum, ileum, and colon (Fig. [5](#fig5){ref-type="fig"}E,F and data not shown), in the CA1--CA3 and dentate gyrus regions of the hippocampus (Fig. [5](#fig5){ref-type="fig"}G), and low levels were also observed in the Purkinje cell layer of the cerebellum (Fig. [5](#fig5){ref-type="fig"}H). Expression was also observed in the lymphoid follicles and Peyer\'s patches, as well as in the FAE of the intestine (data not shown). Altogether, these results show that *Parp‐9* and *Bbap* expression patterns overlap in adult tissues, suggesting that their bidirectional promoter responds to the same regulatory signals. The recent finding that human PARP‐9/BAL1 and BBAP genes respond to IFNγ stimulation strengthens this hypothesis (Juszczynski et al.,[2006](#bib11){ref-type="ref"}).

In summary, we have shown that the macroPARPs *Parp‐9* and *Parp‐14* display distinct expression profiles during mouse development and in adult tissues. *Parp‐9* is developmentally regulated, prominently expressed in the thymus, in specific regions of the central nervous system and of the gut. This regionalized expression pattern during mouse organogenesis suggests that Parp‐9 could have a function in lymphogenesis, neurogenesis, and development of the intestine. In the adult mouse, the highest levels of *Parp‐9* transcripts were found in the medulla of the thymus, suggesting a role for Parp‐9 in thymocytes maturation. Parp‐14 also likely plays a role during thymic development and function, because this organ is the major site of *Parp‐14* expression, although at low levels. Interestingly, human PARP‐9/BAL1 and mouse Parp‐14/Coast6 were reported to act in the transcriptional regulation of gene expression activated by IFNγ and IL‐4, respectively (Goenka and Boothby,[2006](#bib8){ref-type="ref"}; Juszczynski et al.,[2006](#bib11){ref-type="ref"}). These two cytokines can antagonize each other\'s function in thymocytes maturation and macrophage activation during the immune response (Ohmori and Hamilton,[1997](#bib14){ref-type="ref"}), raising the hypothesis of a possible antagonistic function for Parp‐9 and Parp‐14 in the immune response. Parp‐9 was also expressed at higher levels in the enterocytes of the intestine, suggesting specific function(s) that could be related to homeostasis, nutrient digestion, and absorption, or to the barrier and defense function against toxic compounds or pathogenic microorganisms. Finally, we have shown that *Bbap*, the gene sharing a common promoter with *Parp‐9*, is coexpressed with *Parp‐9* during mouse development and in mouse adulthood, suggesting that *Bbap* and *Parp‐9* share a common regulation. However, some additional tissue‐specific gene regulation may exist, with *Parp‐9* being expressed at higher levels in the developing gut than in brain, and with the opposite for *Bbap*. Therefore, *Bbap* and *Parp‐9* display both common and independent tissue‐specific regulations.

EXPERIMENTAL PROCEDURES {#sec1-3}
=======================

Generation of Probes {#sec2-6}
--------------------

DNA templates for producing *Parp‐9*, *Parp‐14*, and *Bbap* riboprobes were generated by polymerase chain reaction (PCR). To amplify *Parp‐9*, PCR was performed with oligonucleotides 5′GAA GAC CCA CGT GGG ACC TGA A and 5′CAC GTG TGC TTG TTA AAC TGA TGT AGA CAC TA on plasmid BC003281 (RZPD, Deutsches Ressourcenzentrum für Genomforschung, Berlin, Germany). The PCR product, encoding full length *Parp‐9*, was cloned into pCRII vector (TA Cloning Kit Dual Promoter pCR II, Invitrogen), and sequence‐verified before linearization with *Bam*HI or *Eco*RV and transcription with T7 or Sp6 RNA polymerases to generate the antisense and sense probes, respectively.

The *Parp‐14* template was generated by nested PCR on cDNA obtained by reverse transcription of total RNA from mouse thymus using a first pair of primers 5′ AGC CGC CAC GTC TTC CAT GTG GTG and 5′ ATT TGT CCT GCT TCA TGT CAC TCC A, and the nested primers 5′GCG TAA TAC GAC TCA CTA TAG GGA CCT TGG AAA AGC AAC AAC AGT G and 5′ GCT ATT TAG GTG ACA CTA TAG GCA GGG ATT TCA GCT TCA GCT TTG A containing the T7 and SP6 promoters, respectively. The resulting probe encoded residues 1106--1622 of Parp‐14.

The *Bbap* template was generated by PCR on cDNA obtained by reverse transcription of total RNA from mouse thymus using the oligonucleotides 5′GCG TAA TAC GAC TCA CTA TAG GGG TCT CCC AAG GTC TTG GCC TG and 5′GCT ATT TAG GTG ACA CTA TAG GCT TTC AGC TCC TCC TTG ACA CGT T, which contain at their 5′ ends the T7 and SP6 promoters, respectively. This probe encoded residues 362--743 of Bbap.

The *Parp‐1* template has been previously described (Schreiber et al.,[2002](#bib16){ref-type="ref"}). Digoxigenin‐labeled (DIG‐RNA labeling Mix, Roche) riboprobes were transcribed in vitro in antisense or sense orientations using T7, Sp6, or T3 RNA polymerases as indicated above. Probes were diluted to 300 ng/μl (for *Parp‐1*, *Parp‐9*, *Bbap* probes) or 600 ng/μl (for *Parp‐14*).

In Situ Hybridization {#sec2-7}
---------------------

Embryos were collected from pregnant CD1 mice at various developmental stages. Adult organs were dissected from 12‐week‐old CD1 male mice, except for brains that were taken from females, and frozen in Shandon Cryomatrix (Thermo Electron Corporation) embedding medium. Serial cryosections (10 or 25 μm) were collected on gelatin‐coated (Superfrost Plus, Kindler) slides. In situ hybridization was performed as described at <http://empress.har.mrc.ac.uk/browser>: gene expression section). Some of the experiments were performed using a Tecan GenePaint Robot and a Tyramide signal amplification method (for details, see <http://www.eurexpress.org> and <http://www.genepaint.org>). In each hybridization experiment, control sense probes were included, allowing the determination of possible false‐positive signal. Two to four embryos and adult organs were analyzed for each probe. The sex of the embryos between E14.5 and E18.5 was determined from the histology of the gonads. At least one male and one female were analyzed for E14.5, E15.5--E16.5, and E17.5--E18.5. No significant difference in the expression patterns was observed between male and female embryos. Except for E17.5 (Fig. [1](#fig1){ref-type="fig"}), all the illustrations represent female embryos.
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